Information and calculation tools by Rachid Asen. Not investment advice or research.

Disclaimer. Information tool. Compiles data published by NSE and BSE and calculations from the exchanges' published ESM and ASM criteria. Prices are end-of-day, not live: updated each evening after trading ends. Ethical business criteria are matched by AI, which can make mistakes; this is a criteria match, not a certification, fatwa, rating or advice. Check the company's filings. Not investment advice, research or a recommendation to buy, sell or hold any security; not SEBI-registered as an Investment Adviser or Research Analyst. Calculated dates are the earliest a security could become eligible; inclusion, stage changes and exit are decided solely by the exchanges. ESM, ASM and GSM shortlisting are surveillance measures and not an adverse action against the company. Data may be delayed or inaccurate; verify with the exchange.

SurveillanceLabby Rachid AsenSupportSign in
Market closedPro tools are for Pro members only. Pro access requires signing an NDA.Pro needs an NDA.Request Pro accessRequest accessIST

BHARAT IMMUNOLOGICALS & BIOLOG

BIBCL (BSE 524663) · ISIN INE994B01014 · Pharmaceuticals · Est. 1989 · listed 1994 · website

GSM Stage 0 · BSE

Open the full company file Every section, filings and your notes, in the app.

Quarterly results

No quarterly results stored for this company yet.

Shareholding

Shareholding pattern, Mar 2024
PromoterFIIDIIPublic
59.25%——40.75%

Latest filings

Other companies in Pharmaceuticals

Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 31 March 2024.

Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.